Addex Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $ | $19 | $29 | $36 |
Gross Profit | 17 | 29 | -198 | |
EBITDA | -1,830 | -972 | -1,574 | -1,955 |
EBIT | -1,833 | -975 | -1,576 | -1,958 |
Net Income | -1,836 | -2,298 | -1,577 | -1,841 |
Net Change In Cash | 19 | 29 | 36 | |
Free Cash Flow | -608 | -608 | -533 | -419 |
Cash | 1,640 | 1,640 | 2,187 | 2,300 |
Basic Shares | 1,186 | 1,186 | 938 | 767 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $29 | $404 | $1,612 | $1,422 |
Gross Profit | 29 | 404 | 1,612 | 1,422 |
EBITDA | -6,831 | -4,645 | -2,190 | -10,452 |
EBIT | -6,840 | -4,905 | -2,496 | -10,776 |
Net Income | -6,728 | 7,055 | -10,556 | -20,804 |
Net Change In Cash | 29 | 404 | 1,612 | 1,422 |
Free Cash Flow | -2,075 | -5,374 | -7,999 | -16,437 |
Cash | 1,640 | 3,341 | 3,865 | 6,957 |
Basic Shares | 935 | 817 | 619 | 376 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$1.33 |
2025-09-30 | -$0.01 |
2025-06-30 | -$0.02 |
2025-03-31 | -$0.01 |